Annual Total Liabilities
$51.10 M
+$21.80 M+74.40%
December 31, 2023
Summary
- As of March 6, 2025, CASI annual total liabilities is $51.10 million, with the most recent change of +$21.80 million (+74.40%) on December 31, 2023.
- During the last 3 years, CASI annual total liabilities has risen by +$26.94 million (+111.51%).
- CASI annual total liabilities is now at all-time high.
Performance
CASI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$49.77 M
+$7.52 M+17.80%
September 1, 2024
Summary
- As of March 6, 2025, CASI quarterly total liabilities is $49.77 million, with the most recent change of +$7.52 million (+17.80%) on September 1, 2024.
- Over the past year, CASI quarterly total liabilities has dropped by -$1.33 million (-2.61%).
- CASI quarterly total liabilities is now -2.61% below its all-time high of $51.10 million, reached on December 31, 2023.
Performance
CASI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CASI Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +74.4% | -2.6% |
| 3 y3 years | +111.5% | -2.6% |
| 5 y5 years | +1194.7% | -2.6% |
CASI Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.4% | -2.6% | +109.2% |
| 5 y | 5-year | at high | +470.0% | -2.6% | +595.5% |
| alltime | all time | at high | +8941.6% | -2.6% | +9826.0% |
CASI Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.77 M(+17.8%) |
| Jun 2024 | - | $42.25 M(-0.7%) |
| Mar 2024 | - | $42.54 M(-16.7%) |
| Dec 2023 | $51.10 M(+74.4%) | $51.10 M(+114.8%) |
| Sep 2023 | - | $23.79 M(-1.0%) |
| Jun 2023 | - | $24.03 M(-8.2%) |
| Mar 2023 | - | $26.17 M(-10.7%) |
| Dec 2022 | $29.30 M(-3.4%) | $29.30 M(-34.4%) |
| Sep 2022 | - | $44.69 M(+52.8%) |
| Jun 2022 | - | $29.25 M(-5.2%) |
| Mar 2022 | - | $30.85 M(+1.7%) |
| Dec 2021 | $30.34 M(+25.6%) | $30.34 M(+13.4%) |
| Sep 2021 | - | $26.76 M(-1.0%) |
| Jun 2021 | - | $27.03 M(+4.4%) |
| Mar 2021 | - | $25.90 M(+7.2%) |
| Dec 2020 | $24.16 M(+169.5%) | $24.16 M(+12.7%) |
| Sep 2020 | - | $21.44 M(+199.6%) |
| Jun 2020 | - | $7.16 M(-13.2%) |
| Mar 2020 | - | $8.24 M(-8.0%) |
| Dec 2019 | $8.97 M(+127.2%) | $8.97 M(+8.8%) |
| Sep 2019 | - | $8.24 M(+5.4%) |
| Jun 2019 | - | $7.82 M(+14.1%) |
| Mar 2019 | - | $6.85 M(+73.5%) |
| Dec 2018 | $3.95 M(-39.8%) | $3.95 M(-43.5%) |
| Sep 2018 | - | $6.99 M(+66.8%) |
| Jun 2018 | - | $4.19 M(+18.2%) |
| Mar 2018 | - | $3.54 M(-46.0%) |
| Dec 2017 | $6.56 M(-5.3%) | $6.56 M(-8.1%) |
| Sep 2017 | - | $7.14 M(+0.4%) |
| Jun 2017 | - | $7.11 M(+2.4%) |
| Mar 2017 | - | $6.94 M(+0.2%) |
| Dec 2016 | $6.93 M(-41.8%) | $6.93 M(-20.7%) |
| Sep 2016 | - | $8.73 M(-2.3%) |
| Jun 2016 | - | $8.94 M(-9.5%) |
| Mar 2016 | - | $9.89 M(-17.0%) |
| Dec 2015 | $11.91 M(+1.6%) | $11.91 M(+0.7%) |
| Sep 2015 | - | $11.83 M(-1.6%) |
| Jun 2015 | - | $12.03 M(+0.1%) |
| Mar 2015 | - | $12.01 M(+2.4%) |
| Dec 2014 | $11.73 M(+1975.7%) | $11.73 M(+1.4%) |
| Sep 2014 | - | $11.57 M(+1456.9%) |
| Jun 2014 | - | $743.30 K(-1.7%) |
| Mar 2014 | - | $755.90 K(+33.7%) |
| Dec 2013 | $565.20 K(-23.9%) | $565.20 K(+12.7%) |
| Sep 2013 | - | $501.40 K(-33.1%) |
| Jun 2013 | - | $749.70 K(-5.7%) |
| Mar 2013 | - | $794.60 K(+7.0%) |
| Dec 2012 | $742.80 K(+5.5%) | $742.80 K(+2.3%) |
| Sep 2012 | - | $726.10 K(-23.1%) |
| Jun 2012 | - | $944.80 K(-90.1%) |
| Mar 2012 | - | $9.58 M(+1260.9%) |
| Dec 2011 | $704.10 K(-74.0%) | $704.10 K(-7.4%) |
| Sep 2011 | - | $760.30 K(-40.7%) |
| Jun 2011 | - | $1.28 M(-25.2%) |
| Mar 2011 | - | $1.71 M(-36.7%) |
| Dec 2010 | $2.70 M | $2.70 M(-41.4%) |
| Sep 2010 | - | $4.61 M(-31.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $6.73 M(-26.9%) |
| Mar 2010 | - | $9.20 M(-23.3%) |
| Dec 2009 | $11.99 M(-47.9%) | $11.99 M(-15.2%) |
| Sep 2009 | - | $14.15 M(-12.0%) |
| Jun 2009 | - | $16.08 M(-14.7%) |
| Mar 2009 | - | $18.86 M(-18.0%) |
| Dec 2008 | $23.00 M(-11.9%) | $23.00 M(-5.4%) |
| Sep 2008 | - | $24.30 M(-5.9%) |
| Jun 2008 | - | $25.82 M(-0.6%) |
| Mar 2008 | - | $25.99 M(-0.5%) |
| Dec 2007 | $26.12 M(+198.3%) | $26.12 M(+0.5%) |
| Sep 2007 | - | $25.99 M(+268.2%) |
| Jun 2007 | - | $7.06 M(-8.6%) |
| Mar 2007 | - | $7.72 M(-11.8%) |
| Dec 2006 | $8.76 M(+24.3%) | $8.76 M(+14.6%) |
| Sep 2006 | - | $7.64 M(+9.9%) |
| Jun 2006 | - | $6.95 M(+3.5%) |
| Mar 2006 | - | $6.71 M(-4.7%) |
| Dec 2005 | $7.05 M(+91.3%) | $7.05 M(+52.9%) |
| Sep 2005 | - | $4.61 M(+45.3%) |
| Jun 2005 | - | $3.17 M(-37.7%) |
| Mar 2005 | - | $5.09 M(+38.2%) |
| Dec 2004 | $3.68 M(-30.2%) | $3.68 M(+44.4%) |
| Sep 2004 | - | $2.55 M(-4.8%) |
| Jun 2004 | - | $2.68 M(-16.2%) |
| Mar 2004 | - | $3.20 M(-39.4%) |
| Dec 2003 | $5.28 M(-69.5%) | $5.28 M(+68.4%) |
| Sep 2003 | - | $3.13 M(+2.6%) |
| Jun 2003 | - | $3.05 M(-49.9%) |
| Mar 2003 | - | $6.10 M(-64.7%) |
| Dec 2002 | $17.30 M(-24.8%) | $17.30 M(-4.1%) |
| Sep 2002 | - | $18.05 M(+36.3%) |
| Jun 2002 | - | $13.24 M(-21.5%) |
| Mar 2002 | - | $16.87 M(-26.7%) |
| Dec 2001 | $23.01 M(+86.2%) | $23.01 M(+13.5%) |
| Sep 2001 | - | $20.26 M(+28.6%) |
| Jun 2001 | - | $15.76 M(+13.0%) |
| Mar 2001 | - | $13.94 M(+12.9%) |
| Dec 2000 | $12.35 M(+25.5%) | $12.35 M(+44.5%) |
| Sep 2000 | - | $8.55 M(-3.4%) |
| Jun 2000 | - | $8.85 M(+21.7%) |
| Mar 2000 | - | $7.28 M(-26.1%) |
| Dec 1999 | $9.84 M(+53.8%) | $9.84 M(+85.7%) |
| Sep 1999 | - | $5.30 M(-13.1%) |
| Jun 1999 | - | $6.10 M(-4.7%) |
| Mar 1999 | - | $6.40 M(0.0%) |
| Dec 1998 | $6.40 M(+12.3%) | $6.40 M(+42.2%) |
| Sep 1998 | - | $4.50 M(-11.8%) |
| Jun 1998 | - | $5.10 M(+8.5%) |
| Mar 1998 | - | $4.70 M(-17.5%) |
| Dec 1997 | $5.70 M(-10.9%) | $5.70 M(+35.7%) |
| Sep 1997 | - | $4.20 M(-26.3%) |
| Jun 1997 | - | $5.70 M(+5.6%) |
| Mar 1997 | - | $5.40 M(-15.6%) |
| Dec 1996 | $6.40 M | $6.40 M(+8.5%) |
| Sep 1996 | - | $5.90 M(-9.2%) |
| Jun 1996 | - | $6.50 M(0.0%) |
| Mar 1996 | - | $6.50 M |
FAQ
- What is CASI Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual total liabilities year-on-year change?
- What is CASI Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly total liabilities year-on-year change?
What is CASI Pharmaceuticals annual total liabilities?
The current annual total liabilities of CASI is $51.10 M
What is the all time high annual total liabilities for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual total liabilities is $51.10 M
What is CASI Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CASI annual total liabilities has changed by +$21.80 M (+74.40%)
What is CASI Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CASI is $49.77 M
What is the all time high quarterly total liabilities for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly total liabilities is $51.10 M
What is CASI Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CASI quarterly total liabilities has changed by -$1.33 M (-2.61%)